跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TAVNEOS
Authorized
STANDARD
TAVNEOS
vifor fresenius medical care renal pharma ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cc97a02b7386153f
Company
vifor fresenius medical care renal pharma ltd
Type
Standard
Approval Details
Approval Id
cc97a02b7386153f
Drug Approval Canada Name
TAVNEOS
Product Name
TAVNEOS
Status
Marketed
Status Date
2022-11-04
Original Market Date
2022-11-04
Din
02526662
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
90:20.00
Atc Original
L04AJ05 AVACOPAN
Atc Name
l 04 aj 05
Aig Number
0163561001
Company Name
vifor fresenius medical care renal pharma ltd
Company Address
Rechenstrasse 37, St Gallen, St Gallen, Switzerland, 9014
Active Ingredients
AVACOPAN
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cc97a02b7386153f
Type
Standard
Back to Health Canada Approvals
TAVNEOS - Health Canada Drug Approval Details